PIVORAS Trademark

Trademark Overview

On Wednesday, January 7, 2004, a trademark application was filed for PIVORAS with the United States Patent and Trademark Office. The USPTO has given the PIVORAS trademark a serial number of 79001020. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, January 8, 2014. This trademark is owned by Novartis AG. The PIVORAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, the immune system, the cardiovascular system, the respiratory system, musculo-skeletal and inflammatory disorders, or for use in dermatology and oncology
pivoras

General Information

Serial Number79001020
Word MarkPIVORAS
Filing DateWednesday, January 7, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, January 8, 2014
Registration Number2951883
Registration DateTuesday, May 17, 2005
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, the immune system, the cardiovascular system, the respiratory system, musculo-skeletal and inflammatory disorders, or for use in dermatology and oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 23, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Thursday, July 24, 2014NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, July 24, 2014DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2013TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, August 21, 2013TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, August 23, 2012TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 23, 2011CANCELLED SECTION 71
Thursday, June 25, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 7, 2006FINAL DECISION PROCESSED AND SENT TO IB
Thursday, March 16, 2006FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, May 17, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, February 22, 2005PUBLISHED FOR OPPOSITION
Wednesday, February 2, 2005NOTICE OF PUBLICATION
Monday, December 20, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 10, 2004ASSIGNED TO LIE
Thursday, December 2, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2004AMENDMENT FROM APPLICANT ENTERED
Wednesday, November 17, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 17, 2004PAPER RECEIVED
Monday, November 15, 2004PAPER RECEIVED
Tuesday, November 16, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 1, 2004REFUSAL PROCESSED BY IB
Thursday, September 9, 2004REFUSAL PROCESSED BY IB
Tuesday, August 31, 2004NON-FINAL ACTION MAILED
Friday, July 23, 2004ASSIGNED TO EXAMINER
Wednesday, March 17, 2004NEW APPLICATION ENTERED IN TRAM
Friday, March 12, 2004SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

pivoras system disorders musculo respiratory skeletal inflammatory dermatology cardiovascular oncology immune